OTCMKTS:OCPNY Olympus (OCPNY) Stock Price, News & Analysis $18.00 -0.25 (-1.37%) As of 01/31/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Olympus Stock (OTCMKTS:OCPNY) Get Olympus alerts:Sign Up Key Stats Today's Range$18.00▼$18.0050-Day Range$18.00▼$18.0052-Week Range$16.80▼$74.99Volume400 shsAverage Volume860,265 shsMarket Capitalization$23.15 billionP/E Ratio21.95Dividend Yield0.44%Price TargetN/AConsensus RatingN/A Company Overview Olympus Corporation (OTCMKTS:OCPNY) is a Tokyo‐based multinational company specializing in precision optics and reprographics products. The company operates through three primary business segments: Medical Systems, Scientific Solutions and Imaging. Each segment focuses on the design, development and distribution of specialized equipment for healthcare, research and consumer applications. Founded in Tokyo in 1919, Olympus has evolved from a manufacturer of microscopes and camera lenses into a leading provider of minimally invasive surgical systems and endoscopic visualization technologies. The company’s Medical Systems division offers endoscopes, visualization platforms and surgical energy devices used in gastroenterology, pulmonology and other medical specialties. Its Scientific Solutions segment supplies high‐performance microscopes, industrial borescopes and metal detectors for research laboratories and quality control in manufacturing. Olympus serves a global customer base across North America, Europe, Asia and other regions, operating through a network of subsidiaries, distributors and service centers. The Imaging business provides digital cameras and related accessories aimed at photography enthusiasts and professionals. With a focus on innovation and quality, Olympus continues to invest in R&D to advance its core technologies and address emerging needs in healthcare and scientific research.AI Generated. May Contain Errors. Read More Receive OCPNY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Olympus and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OCPNY Stock News HeadlinesOlympus Corporation (OLYMY) Q1 2026 Earnings Call TranscriptAugust 9, 2025 | seekingalpha.comOlympus Corporation (OLYMY) Q4 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enforcing that means a $5.39 billion pot must be paid out to everyday Americans. See, virtually every AI model is built off stolen data...September 18 at 2:00 AM | Angel Publishing (Ad)Monroe Capital Supports Olympus Partners' Acquisition of Accelevation Holding Company, LLCFebruary 18, 2025 | businesswire.comOlympus Corporation (OLYMY) Q3 2025 Earnings Call TranscriptFebruary 14, 2025 | seekingalpha.comOlympus Corporation (OLYMY) Q2 2025 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comTim Stroble Appointed as Olympus Insurance Company Chief Executive OfficerMay 11, 2023 | finance.yahoo.comNew Olympus sports complex partnership is latest in $1B+ project's progressFebruary 25, 2023 | bizjournals.comSee More Headlines OCPNY Stock Analysis - Frequently Asked Questions How have OCPNY shares performed this year? Olympus' stock was trading at $18.00 at the beginning of the year. Since then, OCPNY shares have increased by 0.0% and is now trading at $18.00. How were Olympus' earnings last quarter? Olympus Co. (OTCMKTS:OCPNY) announced its earnings results on Thursday, August, 5th. The company reported $0.13 EPS for the quarter, topping the consensus estimate of $0.10 by $0.03. The firm had revenue of $1.75 billion for the quarter, compared to analysts' expectations of $1.49 billion. Olympus had a net margin of 13.80% and a trailing twelve-month return on equity of 24.30%. Does Olympus have any subsidiaries? Olympus subsidiaries include these companies: FH ORTHO SAS, Arc Medical Design Limited, Image Stream Medical Inc, Spirus Medical Inc., Innov-X Systems Inc., Advalytix AG, AIZU OLYMPUS CORPORATION, and more. How do I buy shares of Olympus? Shares of OCPNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/05/2021Today9/18/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Structural clay products Sub-IndustryN/A Current SymbolOTCMKTS:OCPNY CIKN/A Webwww.olympus-global.com Phone(133) 340-2111Fax813-3340-2062Employees31,557Year Founded1919Profitability EPS (Trailing Twelve Months)$0.82 Trailing P/E Ratio21.95 Forward P/E Ratio10.91 P/E Growth1.07Net Income$1.03 billion Net Margins13.80% Pretax MarginN/A Return on Equity24.30% Return on Assets9.30% Debt Debt-to-Equity Ratio0.59 Current Ratio1.99 Quick Ratio1.48 Sales & Book Value Annual Sales$7.74 billion Price / Sales2.99 Cash Flow$1.22 per share Price / Cash Flow14.76 Book Value$3.50 per share Price / Book5.14Miscellaneous Outstanding Shares1,285,890,000Free FloatN/AMarket Cap$23.15 billion OptionableNot Optionable Beta0.70 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:OCPNY) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Olympus Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Olympus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.